100 related articles for article (PubMed ID: 28139528)
1. Polymorphism of p53 in cancer prognosis.
Pillai RM; Nair SA
Indian J Med Res; 2016 Sep; 144(3):314-316. PubMed ID: 28139528
[No Abstract] [Full Text] [Related]
2. Tumor-suppressor p53: implications for tumor development and prognosis.
Kirsch DG; Kastan MB
J Clin Oncol; 1998 Sep; 16(9):3158-68. PubMed ID: 9738588
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the p53 pathway.
Pietsch EC; Humbey O; Murphy ME
Oncogene; 2006 Mar; 25(11):1602-11. PubMed ID: 16550160
[TBL] [Abstract][Full Text] [Related]
4. Need for clarification of data in a recent meta-analysis about TP53 codon 72 polymorphism and cancer susceptibility.
Lu PH; Wei MX; Li C; Shen W; Chen MB
Carcinogenesis; 2011 Mar; 32(3):443; author reply 444. PubMed ID: 21135152
[No Abstract] [Full Text] [Related]
5. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes.
Petitjean A; Achatz MI; Borresen-Dale AL; Hainaut P; Olivier M
Oncogene; 2007 Apr; 26(15):2157-65. PubMed ID: 17401424
[TBL] [Abstract][Full Text] [Related]
6. Polymorphic variants in the p53 pathway.
Murphy ME
Cell Death Differ; 2006 Jun; 13(6):916-20. PubMed ID: 16557270
[No Abstract] [Full Text] [Related]
7. p53 codon 72 polymorphism was associated with vulnerability, progression, but not prognosis of bladder cancer in a Taiwanese population: an implication of structural equation modeling to manage the risks of bladder cancer.
Lin HY; Huang CH; Yu TJ; Wu WJ; Yang MC; Lung FW
Urol Int; 2011; 86(3):355-60. PubMed ID: 21346315
[TBL] [Abstract][Full Text] [Related]
8. The p53 mutation "gradient effect" and its clinical implications.
Zambetti GP
J Cell Physiol; 2007 Nov; 213(2):370-3. PubMed ID: 17671971
[TBL] [Abstract][Full Text] [Related]
9. p53 Mutants Access Epigenetic Pathways to Promote Tumor Growth.
Cancer Discov; 2015 Nov; 5(11):OF2. PubMed ID: 26424413
[TBL] [Abstract][Full Text] [Related]
10. [The tumor suppressor gene p53 (part 2). Applications in human pathology].
Martin A
Ann Pathol; 1995; 15(3):184-91. PubMed ID: 7639854
[No Abstract] [Full Text] [Related]
11. Investigation on the role of p53 codon 72 polymorphism and interactions with tobacco, betel quid, and alcohol in susceptibility to cancers in a high-risk population from North East India.
Ihsan R; Devi TR; Yadav DS; Mishra AK; Sharma J; Zomawia E; Verma Y; Phukan R; Mahanta J; Kataki AC; Kapur S; Saxena S
DNA Cell Biol; 2011 Mar; 30(3):163-71. PubMed ID: 21043833
[TBL] [Abstract][Full Text] [Related]
12. P53 tumor suppression network in cancer epigenetics.
Mishra A; Brat DJ; Verma M
Methods Mol Biol; 2015; 1238():597-605. PubMed ID: 25421682
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of GSTM1, GSTT1, and p53 in Goiânia, Goiás.
Rodrigues DA; Costa IR; Martins JV; E Silva KS; Moura KK
Genet Mol Res; 2015 Dec; 14(4):17358-65. PubMed ID: 26782376
[TBL] [Abstract][Full Text] [Related]
14. Infection of human papillomavirus type 18 and p53 codon 72 polymorphism in lung cancer patients from India.
Jain N; Singh V; Hedau S; Kumar S; Daga MK; Dewan R; Murthy NS; Husain SA; Das BC
Chest; 2005 Dec; 128(6):3999-4007. PubMed ID: 16354872
[TBL] [Abstract][Full Text] [Related]
15. [TP53 mutations and molecular epidemiology].
Otsuka K; Ishioka C
Gan To Kagaku Ryoho; 2007 May; 34(5):683-9. PubMed ID: 17496437
[TBL] [Abstract][Full Text] [Related]
16. [p53 as a molecular target for cancer therapy].
Ishioka C; Osada M; Gamo M; Kanamaru R
Gan To Kagaku Ryoho; 1997 Dec; 24(15):2207-12. PubMed ID: 9422063
[TBL] [Abstract][Full Text] [Related]
17. [Study of the molecular mechanisms controlling activity of protein p53 in the development of new strategies in cancer therapeutics].
Marine Ch
Bull Mem Acad R Med Belg; 2009; 164(5-6):175-80; discussion 180-1. PubMed ID: 20666148
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of the p53 tumor suppressor gene and activation of the Ras oncogene: cooperative events in tumorigenesis.
Solomon H; Brosh R; Buganim Y; Rotter V
Discov Med; 2010 May; 9(48):448-54. PubMed ID: 20515613
[TBL] [Abstract][Full Text] [Related]
19. Need for clarification of data in the recent meta-analysis about p53 polymorphism and gastric cancer risk.
Economopoulos KP; Sergentanis TN
Int J Cancer; 2010 May; 126(10):2509. PubMed ID: 19739120
[No Abstract] [Full Text] [Related]
20. p53 gene mutations and codon 72 polymorphism in ovarian carcinoma patients from Serbia.
Malisic E; Jankovic R; Slavkovic D; Milovic-Kovacevic M; Radulovic S
J BUON; 2010; 15(1):101-6. PubMed ID: 20414935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
